Oncolytics Biotech Inc.
ONC.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.49M | 5.20M | 8.87M | 10.72M | 10.65M |
| Total Receivables | 961.00K | 573.00K | 38.80K | 52.80K | 61.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.03M | 1.07M | 1.18M | 2.33M | 1.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 750.80K | 848.80K |
| Total Current Assets | 7.49M | 6.84M | 10.09M | 13.85M | 12.86M |
|
|
|||||
| Total Current Assets | 7.49M | 6.84M | 10.09M | 13.85M | 12.86M |
| Net Property, Plant & Equipment | 674.00K | 738.00K | 722.20K | 790.40K | 845.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.16M | 7.58M | 10.81M | 14.65M | 13.71M |
|
|
|||||
| Total Accounts Payable | 2.68M | 3.50M | 3.02M | 975.90K | 542.00K |
| Total Accrued Expenses | 2.58M | 2.33M | 2.14M | 2.90M | 2.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 166.00K | 193.00K | 199.60K | 213.40K | 201.80K |
| Total Finance Division Other Current Liabilities | -- | 77.00K | 142.90K | 720.00K | 368.70K |
| Total Other Current Liabilities | -- | 77.00K | 142.90K | 720.00K | 368.70K |
| Total Current Liabilities | 5.42M | 6.10M | 5.50M | 4.81M | 4.01M |
|
|
|||||
| Total Current Liabilities | 5.42M | 6.10M | 5.50M | 4.81M | 4.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 342.00K | 370.00K | 399.90K | 437.70K | 494.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.53M | 4.91M | 4.83M | 4.93M | 4.68M |
| Total Liabilities | 13.29M | 11.38M | 10.73M | 10.18M | 9.19M |
|
|
|||||
| Common Stock & APIC | 427.38M | 419.47M | 362.05M | 363.63M | 340.86M |
| Retained Earnings | -438.74M | -429.50M | -362.53M | -359.69M | -337.01M |
| Treasury Stock & Other | 6.23M | 6.23M | 566.40K | 527.90K | 666.50K |
| Total Common Equity | -5.13M | -3.80M | 82.60K | 4.46M | 4.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.13M | -3.80M | 82.60K | 4.46M | 4.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.13M | -3.80M | 82.60K | 4.46M | 4.52M |
|
|
|||||